Published in Ann Acad Med Stetin on January 01, 2008
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res (2008) 2.43
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29
The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res (2004) 2.01
A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer (2004) 1.96
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol (2011) 1.94
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Res (2012) 1.81
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res (2004) 1.60
Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat (2008) 1.59
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2011) 1.51
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2010) 1.41
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat (2006) 1.34
Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods (2002) 1.30
Hereditary ovarian cancer in Poland. Int J Cancer (2003) 1.30
Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. J Clin Oncol (2013) 1.26
A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet (2013) 1.17
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 1.17
Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling. J Med Genet (2007) 1.14
Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer (2003) 1.13
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 1.12
A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. Eur J Hum Genet (2003) 1.08
CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res (2005) 1.08
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer (2011) 1.06
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat (2006) 1.05
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat (2009) 1.05
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract (2005) 1.04
MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer (2006) 1.04
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet (2006) 1.02
BRCA1 mutations and prostate cancer in Poland. Eur J Cancer Prev (2008) 1.01
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev (2003) 0.99
CDKN2A common variant and multi-organ cancer risk--a population-based study. Int J Cancer (2006) 0.99
A low selenium level is associated with lung and laryngeal cancers. PLoS One (2013) 0.99
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat (2005) 0.99
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat (2006) 0.98
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat (2012) 0.98
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Prostate (2013) 0.97
Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma. Eur J Hum Genet (2006) 0.97
CHEK2 mutation and hereditary breast cancer. J Clin Oncol (2007) 0.96
Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol (2005) 0.96
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology. Breast Cancer Res Treat (2008) 0.95
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat (2009) 0.95
Can selenium levels act as a marker of colorectal cancer risk? BMC Cancer (2013) 0.93
Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer (2005) 0.92
A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer. Breast Cancer Res Treat (2008) 0.92
Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer (2008) 0.92
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev (2013) 0.92
The risk of gastric cancer in carriers of CHEK2 mutations. Fam Cancer (2013) 0.91
Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer (2004) 0.91
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer (2008) 0.90
Association of common WRAP 53 variant with ovarian cancer risk in the Polish population. Mol Biol Rep (2012) 0.90
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer. Breast Cancer Res Treat (2011) 0.90
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2014) 0.89
The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett (2008) 0.89
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat (2006) 0.89
BRCA1 mutations and colorectal cancer in Poland. Fam Cancer (2010) 0.89
Sulforaphane-mediated induction of a phase 2 detoxifying enzyme NAD(P)H:quinone reductase and apoptosis in human lymphoblastoid cells. Acta Biochim Pol (2004) 0.89
A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene (2013) 0.89
A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat (2007) 0.89
High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat (2005) 0.88
A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers. Cancer Epidemiol Biomarkers Prev (2011) 0.88
Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer. Int J Cancer (2008) 0.88
Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One (2011) 0.88
The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev (2010) 0.87